Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV002021554 | SCV002315550 | benign | not provided | 2023-11-27 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV004671625 | SCV005156472 | uncertain significance | not specified | 2024-04-06 | criteria provided, single submitter | clinical testing | The c.43G>A (p.V15I) alteration is located in exon 3 (coding exon 1) of the RNF13 gene. This alteration results from a G to A substitution at nucleotide position 43, causing the valine (V) at amino acid position 15 to be replaced by an isoleucine (I). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |